FindTrial
Sign In

Outcome of endotherapy for Pancreatic Divisum

To study the outcome of endotherapy for pancreatic divisum in patients of Recurrent Acute Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019332
Enrollment
40
Registered
2019-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K868- Other specified diseases of pancreas

Interventions

Intervention1: NIL: NOT APPLICABLE Intervention2: NIL: NOT APPLICABLE

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group between 18 to 60 years of either sex 2.Patients having at least 2 documented episodes of pancreatitis within 1 year without any evidence of chronic pancreatitis. 3.Patients diagnosed with pancreatic divisum on MRCP/EUS.

Exclusion criteria

Exclusion criteria: 1. Patients who show changes of chronic pancreatitis in pancreatic divisum 2. Patients who refuse informed consent form 3. Pregnancy 4. Malignancy 5. Gall stone pancreatitis, alcohol induced pancreatitis, hypertriglyceridemia, hypercalcemia

Design outcomes

Primary

MeasureTime frame
Technical and clinical successTimepoint: At end of study—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Amol Vadgaonkar

Baldota Institute of Digestive Sciences

prabhasawant@hotmail.com9820901875

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026